Walleye Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.54M | Sell |
14,400
-3,800
| -21% | -$1.89M | 0.01% | 876 |
|
|
2025
Q4 | $8.87M | Sell |
18,200
-28,700
| -61% | -$13.4M | 0.01% | 994 |
|
|
2025
Q3 | $19.7M | Buy |
46,900
+13,200
| +39% | +$4.44M | 0.03% | 596 |
|
|
2025
Q2 | $9.68M | Buy |
33,700
+13,300
| +65% | +$3.97M | 0.02% | 835 |
|
|
2025
Q1 | $6.29M | Buy |
20,400
+19,200
| +1,600% | +$6.58M | 0.01% | 958 |
|
|
2024
Q4 | $423K | Sell |
1,200
-4,600
| -79% | -$1.69M | ﹤0.01% | 2735 |
|
|
2024
Q3 | $2.08M | Buy |
5,800
+5,600
| +2,800% | +$1.89M | ﹤0.01% | 1658 |
|
|
2024
Q2 | $63.7K | Sell |
200
-6,200
| -97% | -$1.64M | ﹤0.01% | 3514 |
|
|
2024
Q1 | $1.47M | Sell |
6,400
-16,300
| -72% | -$3.68M | ﹤0.01% | 1932 |
|
|
2023
Q4 | $4.99M | Buy |
22,700
+17,200
| +313% | +$3.96M | 0.01% | 1244 |
|
|
2023
Q3 | $1.24M | Buy |
5,500
+5,000
| +1,000% | +$1.15M | ﹤0.01% | 2180 |
|
|
2023
Q2 | $110K | Buy |
500
+200
| +67% | +$44.3K | ﹤0.01% | 3708 |
|
|
2023
Q1 | $67.2K | Sell |
300
-3,500
| -92% | -$863K | ﹤0.01% | 3993 |
|
|
2022
Q4 | $1.06M | Sell |
3,800
-6,300
| -62% | -$1.59M | ﹤0.01% | 2175 |
|
|
2022
Q3 | $2.12M | Buy |
10,100
+8,300
| +461% | +$1.86M | 0.01% | 1634 |
|
|
2022
Q2 | $424K | Sell |
1,800
-400
| -18% | -$81.3K | ﹤0.01% | 3054 |
|
|
2022
Q1 | $395K | Sell |
2,200
-2,600
| -54% | -$495K | ﹤0.01% | 3145 |
|
|
2021
Q4 | $1.04M | Sell |
4,800
-19,100
| -80% | -$3.75M | ﹤0.01% | 2208 |
|
|
2021
Q3 | $4.41M | Sell |
23,900
-200
| -0.8% | -$39.4K | 0.02% | 1005 |
|
|
2021
Q2 | $4.32M | Sell |
24,100
-22,200
| -48% | -$4.23M | 0.02% | 890 |
|
|
2021
Q1 | $7.75M | Buy |
46,300
+42,100
| +1,002% | +$7.02M | 0.03% | 436 |
|
|
2020
Q4 | $638K | Buy |
4,200
+4,100
| +4,100% | +$538K | ﹤0.01% | 2437 |
|
|
2020
Q3 | $10K | Sell |
100
-6,400
| -98% | -$702K | ﹤0.01% | 3918 |
|
|
2020
Q2 | $787K | Sell |
6,500
-2,100
| -24% | -$236K | 0.01% | 1871 |
|
|
2020
Q1 | $815K | Buy |
8,600
+2,400
| +39% | +$228K | 0.01% | 1459 |
|
|
2019
Q4 | $546K | Buy |
6,200
+1,200
| +24% | +$106K | ﹤0.01% | 2331 |
|
|
2019
Q3 | $399K | Buy |
5,000
+400
| +9% | +$32.2K | ﹤0.01% | 2364 |
|
|
2019
Q2 | $359K | Sell |
4,600
-7,300
| -61% | -$683K | ﹤0.01% | 2466 |
|
|
2019
Q1 | $1.4M | Buy |
11,900
+10,000
| +526% | +$1.17M | 0.01% | 1363 |
|
|
2018
Q4 | $207K | Buy |
+1,900
| New | +$220K | ﹤0.01% | 3369 |
|
|
2018
Q3 | – | Sell |
-500
| Closed | -$57K | – | 5571 |
|
|
2018
Q2 | $57K | Buy |
+500
| New | +$55K | ﹤0.01% | 4214 |
|
|
2017
Q1 | – | Sell |
-9,200
| Closed | -$1.32M | – | 5187 |
|
|
2016
Q4 | $1.32M | Hold |
9,200
| – | – | 0.01% | 1299 |
|
|
2016
Q3 | $1.09M | Hold |
9,200
| – | – | 0.01% | 1473 |
|
|
2016
Q2 | $974K | Buy |
+9,200
| New | +$1.03M | 0.01% | 1627 |
|
|
2015
Q3 | – | Sell |
-600
| Closed | -$104K | – | 5530 |
|
|
2015
Q2 | $104K | Buy |
+600
| New | +$108K | ﹤0.01% | 3010 |
|
Other funds holding UTHR
ACA
VPM
VCM
Walleye Trading's UTHR Position: Q1 2026 in Review
Walleye Trading sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 7,066 shares — an estimated $3.52M sold.
Walleye Trading first reported a position in UTHR in Q2 2015 and held it in 27 quarters. The position peaked at $6M in Q2 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Walleye Trading reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Walleye Trading sold 7,066 United Therapeutics shares in Q1 2026, an estimated $3.52M.
- Walleye Trading first reported a position in United Therapeutics in Q2 2015 and held it in 27 quarters.
- Walleye Trading's United Therapeutics position peaked at $6M in Q2 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.